Hatchell DL - Search Results

1

The safety of intravitreal hyaluronidase. A clinical and histologic study.

Gottlieb JL, Antoszyk AN, Hatchell DL, Saloupis P. Gottlieb JL, et al. Among authors: hatchell dl. Invest Ophthalmol Vis Sci. 1990 Nov;31(11):2345-52. Invest Ophthalmol Vis Sci. 1990. PMID: 2242999

2

Treatment of experimental preretinal neovascularization using photodynamic thrombosis.

Wilson CA, Saloupis P, Hatchell DL. Wilson CA, et al. Among authors: hatchell dl. Invest Ophthalmol Vis Sci. 1991 Aug;32(9):2530-5. Invest Ophthalmol Vis Sci. 1991. PMID: 1714431

3

An experimental model of preretinal neovascularization in the rabbit.

Antoszyk AN, Gottlieb JL, Casey RC, Hatchell DL, Machemer R. Antoszyk AN, et al. Among authors: hatchell dl. Invest Ophthalmol Vis Sci. 1991 Jan;32(1):46-52. Invest Ophthalmol Vis Sci. 1991. PMID: 1987106

4

Reduction of basement membrane thickening in diabetic cat retina by sulindac.

Mansour SZ, Hatchell DL, Chandler D, Saloupis P, Hatchell MC. Mansour SZ, et al. Among authors: hatchell mc, hatchell dl. Invest Ophthalmol Vis Sci. 1990 Mar 1;31(3):457-63. Invest Ophthalmol Vis Sci. 1990. PMID: 2318584

5

Role of neutrophils in breakdown of the blood-retinal barrier following intravitreal injection of platelet-activating factor.

Smith D, Lee EK, Saloupis P, Davis JK, Hatchell DL. Smith D, et al. Among authors: hatchell dl. Exp Eye Res. 1994 Oct;59(4):425-32. doi: 10.1006/exer.1994.1127. Exp Eye Res. 1994. PMID: 7859817

6

The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization.

Antoszyk AN, Gottlieb JL, Machemer R, Hatchell DL. Antoszyk AN, et al. Among authors: hatchell dl. Graefes Arch Clin Exp Ophthalmol. 1993;231(1):34-40. doi: 10.1007/BF01681698. Graefes Arch Clin Exp Ophthalmol. 1993. PMID: 8428678

7

Aclacinomycin A in the treatment of experimental proliferative vitreoretinopathy. Efficacy and toxicity in the rabbit eye.

Steinhorst UH, Chen EP, Hatchell DL, Samsa GP, Saloupis PT, Westendorf J, Machemer R. Steinhorst UH, et al. Among authors: hatchell dl. Invest Ophthalmol Vis Sci. 1993 Apr;34(5):1753-60. Invest Ophthalmol Vis Sci. 1993. PMID: 8473115

8

The effect of combined daunorubicin and triamcinolone acetonide treatment on a refined experimental model of proliferative vitreoretinopathy.

Chen EP, Steinhorst UH, Samsa GP, Saloupis PT, Hatchell DL. Chen EP, et al. Among authors: hatchell dl. Invest Ophthalmol Vis Sci. 1992 Jun;33(7):2160-4. Invest Ophthalmol Vis Sci. 1992. PMID: 1607226

9

Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy.

Khawly JA, Saloupis P, Hatchell DL, Machemer R. Khawly JA, et al. Among authors: hatchell dl. Graefes Arch Clin Exp Ophthalmol. 1991;229(5):464-7. doi: 10.1007/BF00166311. Graefes Arch Clin Exp Ophthalmol. 1991. PMID: 1937080

10

Neutrophils plug capillaries in acute experimental retinal ischemia.

Hatchell DL, Wilson CA, Saloupis P. Hatchell DL, et al. Microvasc Res. 1994 May;47(3):344-54. doi: 10.1006/mvre.1994.1027. Microvasc Res. 1994. PMID: 8084299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters